Pages that link to "Q37204957"
Jump to navigation
Jump to search
The following pages link to Predictive value of four kallikrein markers for pathologically insignificant compared with aggressive prostate cancer in radical prostatectomy specimens: results from the European Randomized Study of Screening for Prostate Cancer section Rotterdam. (Q37204957):
Displaying 35 items.
- The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology Advancements (Q26750672) (← links)
- PSA and beyond: alternative prostate cancer biomarkers (Q26770646) (← links)
- Potential Utility of Novel Biomarkers in Active Surveillance of Low-Risk Prostate Cancer (Q26784517) (← links)
- Biomarkers in prostate cancer: what's new? (Q27026210) (← links)
- Serum markers in prostate cancer detection (Q35042519) (← links)
- The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men. (Q35532150) (← links)
- A novel DNA methylation score accurately predicts death from prostate cancer in men with low to intermediate clinical risk factors. (Q37687723) (← links)
- Recent progress and perspectives on prostate cancer biomarkers (Q37736079) (← links)
- 4-Kallikrein Test and Kallikrein Markers in Prostate Cancer Screening (Q38650674) (← links)
- Biomarkers in localized prostate cancer (Q38697114) (← links)
- Screening and Detection of Prostate Cancer-Review of Literature and Current Perspective (Q38762709) (← links)
- Clinical Utility of Biomarkers in Localized Prostate Cancer. (Q38792354) (← links)
- Primary Gleason pattern upgrading in contemporary patients with D'Amico low-risk prostate cancer: implications for future biomarkers and imaging modalities (Q38846321) (← links)
- Kallikrein-Related Peptidases in Prostate Cancer: From Molecular Function to Clinical Application (Q38967490) (← links)
- Prognostic role of genetic biomarkers in clinical progression of prostate cancer (Q38976733) (← links)
- The role of prostate cancer biomarkers in undiagnosed men. (Q39140686) (← links)
- Finding the Wolf in Sheep's Clothing: The 4Kscore Is a Novel Blood Test That Can Accurately Identify the Risk of Aggressive Prostate Cancer. (Q40284624) (← links)
- Detection of High Grade Prostate Cancer among PLCO Participants Using a Prespecified 4-Kallikrein Marker Panel (Q40417671) (← links)
- The 4Kscore blood test accurately identifies men with aggressive prostate cancer prior to prostate biopsy with or without DRE information. (Q40469023) (← links)
- A proposal of a new nomogram for predicting upstaging in contemporary D'Amico low-risk prostate cancer patients (Q40706344) (← links)
- Nanowire analysis of cancer-testis antigens as biomarkers of aggressive prostate cancer (Q41496498) (← links)
- Whom to Biopsy: Prediagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators. (Q47436741) (← links)
- Biomarkers for Prostate Biopsy and Risk Stratification of Newly Diagnosed Prostate Cancer Patients (Q47718669) (← links)
- A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationale (Q47759609) (← links)
- The effect of digital rectal exam on the 4Kscore for aggressive prostate cancer. (Q49822288) (← links)
- A Rich Array of Prostate Cancer Molecular Biomarkers: Opportunities and Challenges (Q64253447) (← links)
- Preoperative Serum Prostate-Specific Antigen Levels Vary According to the Topographical Distribution of Prostate Cancer in Prostatectomy Specimens (Q85857400) (← links)
- Presence of Magnetic Resonance Imaging Suspicious Lesion Predicts Gleason 7 or Greater Prostate Cancer in Biopsy-Naive Patients (Q86643528) (← links)
- Differentiating Molecular Risk Assessments for Prostate Cancer (Q89243889) (← links)
- A predictive model for prostate cancer incorporating PSA molecular forms and age (Q89686231) (← links)
- Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore (Q90353952) (← links)
- Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer (Q92476115) (← links)
- Editorial Comment (Q95563128) (← links)
- Detection and Prognosis of Prostate Cancer Using Blood-Based Biomarkers (Q95854974) (← links)
- A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy (Q95936595) (← links)